Old Web
English
Sign In
Acemap
>
authorDetail
>
Karla Rodriguez-Lopez
Karla Rodriguez-Lopez
Merck & Co.
Internal medicine
Medicine
Renal cell carcinoma
Oncology
Lenvatinib
2
Papers
0
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Analysis of the CLEAR study in patients (pts) with advanced renal cell carcinoma (RCC): Depth of response and efficacy for selected subgroups in the lenvatinib (LEN) + pembrolizumab (PEMBRO) and sunitinib (SUN) treatment arms.
2021
Journal of Clinical Oncology
Viktor Grünwald
Thomas Powles
Evgeny Kopyltsov
Vadim Kozlov
Teresa Alonso-Gordoa
Masatoshi Eto
Thomas E. Hutson
Robert J. Motzer
Eric Winquist
Pablo Maroto-Rey
Bhumsuk Keam
Giuseppe Procopio
Shirley Wong
Bohuslav Melichar
Frederic Rolland
Mototsugu Oya
Karla Rodriguez-Lopez
Kenichi Saito
Alan D. Smith
Camillo Porta
Show All
Source
Cite
Save
Citations (0)
Post hoc analysis of the CLEAR study in advanced renal cell carcinoma (RCC): Effect of subsequent therapy on survival outcomes in the lenvatinib (LEN) + everolimus (EVE) versus sunitinib (SUN) treatment arms.
2021
Journal of Clinical Oncology
Thomas E. Hutson
Toni K. Choueiri
Robert J. Motzer
Sun Young Rha
Anna Alyasova
Jaime R. Merchan
Howard Gurney
Avivit Peer
Toshio Takagi
Camillo Porta
Thomas Powles
Viktor Grünwald
Ugo De Giorgi
Ulka N. Vaishampayan
Manuela Schmidinger
Hilary Glen
Karla Rodriguez-Lopez
Dongyuan Xing
Lea Dutta
Masatoshi Eto
Show All
Source
Cite
Save
Citations (0)
1